Candesant Biomedical: Funding, Investors & Team (Aug 2026)
Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Its device is designed to target and inactivate the most active sweat glands. The company was founded in 2016 and is headquartered in San Francisco, California.
Candesant Biomedical has raised $35.0M across 1 funding round on record, the most recent a Series B of $35.0M announced in Jun 2023.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Candesant Biomedical Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Candesant Biomedical Funding Rounds
Candesant Biomedical Founders and Leadership Team
Contact details for the Candesant Biomedical team: 1 of 1 has an email address on file.
Start 14-day free trial →Candesant Biomedical Funding Compared to Other Health Care Startups
Candesant Biomedical's latest round of $35.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Candesant Biomedical in Health Care and San Francisco
Companies Similar to Candesant Biomedical
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
Candesant Biomedical Funding FAQs
What does Candesant Biomedical do?
Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Its device is designed to target and inactivate the most active sweat glands. The company was founded in 2016 and is headquartered in San Francisco, California.
How much funding has Candesant Biomedical raised?
Candesant Biomedical has raised $35.0M across 1 round on record. The most recent is a Series B of $35.0M announced in Jun 2023.
When did Candesant Biomedical last raise funding?
Candesant Biomedical's most recent funding round on record is a Series B of $35.0M, announced in Jun 2023.
Who founded Candesant Biomedical?
FundedIQ lists Niquette Hunt (Founder) at Candesant Biomedical.
Where is Candesant Biomedical headquartered?
Candesant Biomedical is based in San Francisco, California, United States.
How many employees does Candesant Biomedical have?
Candesant Biomedical is in the 11-50 employee band.
How does Candesant Biomedical's funding compare to other Health Care startups?
Candesant Biomedical's latest round of $35.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Candesant Biomedical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Candesant Biomedical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.